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Objective: Biochemical changes associated with obesity may accelerate osteoarthritis beyond 
the effect of mechanical factors. This study investigated whether metabolic syndrome and its 
components (visceral obesity, hypertension, dyslipidemia and insulin resistance) were risk 
factors for subsequent total hip replacement (THR) or total knee replacement (TKR) due to 
primary osteoarthritis.
Design: In this prospective cohort study, data from the second survey of the Nord-Trøndelag 
Health Study 2 (HUNT2) were linked to the Norwegian Arthroplasty Register for identification 
of the outcome of THR or TKR. The analyses were stratified by age (<50, 50–69.9 and ≥70 
years) and adjusted for gender, body mass index, smoking, physical activity and education.
Results: Of the 62,661 participants, 12,593 (20.1%) were identified as having metabolic syn-
drome, and we recorded 1,840 (2.9%) THRs and 1,111 (1.8%) TKRs during a mean follow-up 
time of 15.4 years. Cox regression analyses did not show any association between full metabolic 
syndrome and THR or TKR, except in persons <50 years with metabolic syndrome who had a 
decreased risk of THR (hazard ratio [HR] 0.58, 95% CI 0.40–0.83). However, when including 
only participants whose exposure status did not change during follow-up, this protective asso-
ciation was no longer significant. Increased waist circumference was associated with increased 
risk of TKR in participants <50 years (HR 1.62, 95% CI 1.10–2.39) and 50–69.9 years (HR 
1.43, 95% CI 1.14–1.80). Hypertension significantly increased the risk of TKR in participants 
<50 years (HR 1.38, 95% CI 1.05–1.81), and this risk was greater for men.
Conclusion: This study found an increased risk of TKR in men <50 years with hypertension 
and persons <70 years with increased waist circumference. Apart from this, neither metabolic 
syndrome nor its components were associated with increased risk of THR or TKR due to pri-
mary osteoarthritis.
Keywords: osteoarthritis, metabolic syndrome, total hip replacement, total knee replacement
Introduction
Hip and knee osteoarthritis cause significant morbidity and disability in a large propor-
tion of the population.1 There is no curative treatment for osteoarthritis, and this places 
the emphasis on identifying preventable risk factors. Increased body mass index (BMI) 
is a well-established risk factor for osteoarthritis, both in the knee2–4 and the hip.5–7 
However, biochemical changes associated with obesity may accelerate osteoarthritis 
beyond the effect of mechanical factors.8,9 Metabolic osteoarthritis has, therefore, 
been suggested as a subtype of osteoarthritis, and links between this phenotype and 
metabolic syndrome have been reported.10,11
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Metabolic syndrome is a cluster of components associ-
ated with increased risk of cardiovascular disease.12 These 
include increased waist circumference, high blood pressure, 
elevated triglycerides, reduced high-density lipoprotein 
(HDL) and elevated serum glucose or diabetes. Due to the 
high prevalence of these components among persons with 
osteoarthritis, it has been suggested that metabolic syndrome 
may influence the development of osteoarthritis independent 
of BMI.13,14 This could be explained by shared mechanisms 
in the etiologies of osteoarthritis and metabolic syndrome: 
inflammation, oxidative stress, common metabolites and 
endothelial dysfunction.11 However, it is possible that osteo-
arthritis and metabolic syndrome simply coexist through their 
common shared risk factors of age and obesity.15
The results of observational studies in humans have 
been inconsistent. One Australian prospective cohort study 
found that a cumulative number of metabolic syndrome 
components, central obesity and hypertension were associ-
ated with increased risk of total knee replacement (TKR) 
due to osteoarthritis independent of BMI, but no associations 
were observed for total hip replacement (THR).15 However, 
the Malmö Diet and Cancer Study found that only central 
obesity was associated with increased risk of knee osteo-
arthritis independent of BMI.16 Metabolic syndrome and 
its components were not associated with hip osteoarthritis. 
Other studies have also reported an increased risk of knee 
osteoarthritis associated with an increase in the number of 
metabolic syndrome components.17 In contrast, a recent study 
reported that, after adjustment for BMI, neither metabolic 
syndrome nor its components were associated with incident 
osteoarthritis in the knee.18 The hypothesis of this study was 
that metabolic syndrome is a risk factor for THR or TKR 
due to osteoarthritis.
The aim of this large prospective study was to assess 
whether metabolic syndrome or its components were risk 
factors independent of BMI for subsequent THR or TKR 
due to primary osteoarthritis.
Methods
Study population
Between 1995 and 1997, all inhabitants of Nord-Trøndelag 
county, aged ≥20 years, were invited to participate in the sec-
ond wave of the Nord-Trøndelag Health Study 2 (HUNT2).19 
The HUNT studies include three population-based studies: 
HUNT1 (1984–1986), HUNT2 (1995–1997) and HUNT3 
(2006–2008). HUNT was initially intended to investigate 
arterial hypertension, diabetes, quality of life and to screen for 
tuberculosis. However, its scope expanded over time.19 This 
study included baseline data from HUNT2, as the HUNT1 
study did not have information on serum triglycerides and 
HDL.
A total of 65,237 (69.5%) individuals accepted the invita-
tion to participate in HUNT2.19 From this group, we included 
63,617 participants with measurements of all metabolic syn-
drome components at baseline. Of these, 956 were excluded 
(Figure 1) due to previous joint replacement in the hip or knee 
(n=796), missing date of operation (n=158) or emigration 
during baseline period (n=2). Thus, a total of 62,661 persons 
(32,990 women and 29,671 men) were included in this study. 
Each participant contributed person-time from participation 
date in HUNT2 (between August 1995 and June 1997) until 
total hip or knee replacement due to osteoarthritis, total hip 
Figure 1 Flowchart.
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Metabolic syndrome and THR or TKR: a prospective cohort study
or knee replacement due to other causes, migration, death 
or the end of follow-up (December 31, 2013), whichever 
occurred first.
Clinical measurements
The participants were asked to complete a self-administered 
questionnaire which included a range of health-related ques-
tions. Participants were seen once for clinical measurements 
and blood sampling. The survey included standardized 
measurement of height, weight, waist circumference and 
blood pressure by trained nurses or technicians. Weight was 
measured to the nearest half kilogram with the participants 
wearing light clothes and no shoes. Waist circumference was 
measured horizontally at the height of the umbilicus to the 
nearest centimeter, with the participants standing with their 
arms hanging relaxed. Blood pressure was measured on the 
right arm with cuffs adjusted according to the arm circum-
ference, and after the participant had been sitting relaxed 
for 5 minutes. Measurements based on oscillometry were 
then taken (Dinamap 845XT; Critikon, Tampa, FL, USA). 
Systolic and diastolic blood pressure levels were then read 
three times at 1-minute interval, and the mean of the second 
and third readings was used in the analysis. Non-fasting blood 
samples were drawn from each participant. Serum levels of 
triglycerides, HDL cholesterol and glucose were analyzed on 
a Hitachi 911 Autoanalyser (Hitachi, Mito, Japan).20
According to the Joint Interim Statement, metabolic 
syndrome is defined as the presence of ≥3 of the follow-
ing:12 waist circumference ≥88 cm in women and ≥102 cm in 
men, systolic blood pressure ≥130 mmHg or diastolic blood 
pressure ≥85 mmHg or use of antihypertensive medication, 
triglycerides ≥1.7 mmol/L, HDL cholesterol <1.3 mmol/L in 
women and <1.0 mmol/L in men, and glucose >5.6 mmol/L 
or self-reported diabetes. This definition is based on fasting 
blood samples. When these were lacking, we used a modi-
fied definition of metabolic syndrome also used in previous 
studies,21,22 categorizing elevated glucose as serum glucose 
≥11.1 mmol/L. This is, however, likely to be a stricter cutoff, 
since it is intended to identify undiagnosed diabetes.23 The 
self-reported diagnosis of diabetes in the HUNT study has 
been validated in a separate study, demonstrating that 96.4% 
of self-reported diabetes could be verified in medical files.24
To reduce potential confounding, covariates associated 
with both metabolic syndrome and joint replacement due to 
osteoarthritis were adjusted for. These covariates included: 
age (stratified), gender (female/male), BMI (continuous), 
current smoking status (never, former, current), physical 
activity (light, medium, hard) and education (primary, 
secondary, post-secondary). Cardiovascular disease was 
evaluated to be a mediator, and was therefore not included 
as a confounder as this could have biased the analyses. The 
main analysis was done stepwise; the first model was only 
adjusted for gender and BMI (Model 1) and the second was 
fully adjusted (Model 2). Age was stratified into the age 
groups of <50, 50–69.9 and ≥70 years at baseline. Physical 
activity was categorized by duration of light (not sweating 
or out of breath) physical activity (none, <1, 1–2, ≥3 hours/
week) and/or duration of hard (sweating or out of breath) 
physical activity (none, <1, 1–2, ≥3 hours/week). The physi-
cal activity questions have previously been validated among 
men between 20 and 39 years.25 This showed acceptable 
repeatability and validity for the “hard” physical activity 
questions, but poor validity for the light questions. The two 
physical activity variables were combined into one variable 
indicating intensity and duration: none (no activity), medium 
(≤2 hours/week light physical activity and/or <1 hour/week 
hard physical activity) or hard (≥3 hours/week light physical 
activity and/or ≥1 hour/week hard physical activity). Educa-
tion was defined as the highest level of completed education 
(primary/vocational, secondary or post-secondary).
To account for potential change in exposure during 
follow-up, a sensitivity analysis was performed in those 
who participated in both HUNT2 (1995–1997) and HUNT3 
(2006–2008), with n=30,651. By excluding those who 
changed exposure group between HUNT2 and HUNT3, we 
were able to do an analysis with a lower risk of misclassifica-
tion of the exposures.
As very few of those between 20 and 30 years at baseline 
were expected to have a primary THR or TKR due to osteo-
arthritis, a separate sensitivity analysis also excluded those 
<30 years in the age group <50 years. Finally, we also did 
an analysis stratified on both gender and age to investigate 
any differences between genders.
Outcome
This study used THR or TKR due to primary osteoarthritis 
as the outcome. The unique 11-digit identification number 
of every Norwegian citizen enabled linkage of HUNT data 
to the Norwegian Arthroplasty Register (NAR). NAR was 
established in 1987 and includes all artificial joints from 
1994 onward. The completeness of THR and TKR registra-
tion is over 95%.26 For each arthroplasty performed, the 
orthopedic surgeon submits a standardized form containing 
information about the patient, the diagnosis that led to the 
arthroplasty, the procedure and the type of implant used.27 
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or idiopathic osteoarthritis is considered to be an indicator 
of severe osteoarthritis.
Statistical methods
Cox proportional hazards regression models were used to 
estimate hazard ratios (HRs) with 95% CIs for metabolic 
syndrome, and its components, for the first recorded primary 
THR or TKR due to osteoarthritis. Tests of proportional 
hazards assumption were evaluated by Schoenfeld residuals 
and log-minus-log plots (Table S1) and were satisfied for 
all variables, except for age. The analyses were, therefore, 
stratified into age groups (<50, 50–69.9 and ≥70 years) and 
adjusted for gender, BMI, smoking, physical activity and 
education. The analyses were performed using Stata 14/IC 
(StataCorp LP, College Station, TX, USA).
Ethics approval
This study was approved by the Norwegian Regional Com-
mittee for Ethics in Medical Research (REK Sør-Øst C).
Results
Of the 62,661 participants included in this study, 12,593 
(20.1 %) were identified as having metabolic syndrome 
using the modified definition from Joint Interim State-
ment with a cutoff for non-fasting blood glucose of 
≥11.1 mmol/L. The most prevalent components in persons 
with metabolic syndrome were hypertension, increased 
triglycerides and low HDL. Members of this group were 
generally older, had higher BMI, were less physically active, 
had lower levels of education and higher prevalence of car-
diovascular disease than those without metabolic syndrome 
Table 1 Baseline characteristics
Women Men Total
MetS, n (%) No MetS, n (%) MetS, n (%) No MetS, n (%) MetS, n (%) No MetS, n (%)
Age, years
19–29 301 (4.3) 4,327 (16.7) 390 (7.0) 3,661 (15.2) 691 (5.5) 7,988 (16.0)
30–39 563 (8.0) 5,392 (20.8) 727 (13.1) 4,623 (19.2) 1,290 (10.2) 10,015 (20.0)
40–49 1,037 (14.7) 5,952 (22.9) 1,084 (19.5) 5,372 (22.3) 2,121 (16.8) 11,324 (22.6)
50–59 1,287 (18.3) 4,337 (16.7) 1,058 (19.0) 4,203 (17.4) 2,345 (18.7) 8,540 (17.1)
60–69 1,558 (22.2) 2,911 (11.2) 1,038 (18.7) 3,148 (13.0) 2,596 (20.6) 6,059 (12.1)
70–79 1,663 (23.6) 2,280 (8.8) 956 (17.2) 2,434 (10.1) 2,619 (20.8) 4,714 (9.4)
≥80 626 (8.9) 756 (2.9) 305 (5.5) 672 (2.8) 931 (7.4) 1,428 (2.8)
Gender
Women 7,035 (55.9) 25,955 (51.8)
BMI, kg/m2
<18.5 7 (0.1) 328 (1.3) 4 (0.1) 109 (0.5) 11 (0.1) 437 (0.9)
18.5–24.99 696 (9.9) 13,739 (52.9) 499 (9.0) 9,853 (40.8) 1,195 (9.5) 23,592 (47.1)
25–29.99 2,794 (39.7) 9,400 (36.2) 2,710 (48.7) 12,244 (50.8) 5,504 (43.7) 21,644 (43.2)
≥30 3,538 (50.3) 2,488 (9.6) 2,345 (42.2) 1,907 (7.9) 5,883 (46.7) 4,395 (8.8)
Smoking
Never 3,536 (52.1) 11,958 (47.1) 1,715 (31.5) 9,274 (39.1) 5,251 (42.9) 21,232 (43.2)
Former 1,492 (22.0) 5,546 (21.8) 2,305 (42.4) 7,457 (31.4) 3,797 (31.1) 13,003 (26.5)
Current 1,763 (25.9) 7,899 (31.1) 1,419 (26.1) 7,007 (29.5) 3,182 (26.0) 14,906 (30.3)
Missing 244 552 119 375 363 927
Physical activity
None 791 (14.4) 1,442 (6.1) 575 (11.7) 1,620 (7.3) 1,366 (13.1) 3,062 (6.7)
Medium 3,169 (57.7) 12,749 (54.3) 2,623 (53.2) 10,375 (46.5) 5,792 (55.6) 23,124 (50.5)
Hard 1,530 (27.9) 9,291 (39.6) 1,729 (35.1) 10,321 (46.2) 3,259 (31.3) 19,612 (42.8)
Missing 1,545 2,473 631 1,797 2,176 4,270
Education
Primary/vocational 5,415 (86.5) 16,127 (64.8) 4,077 (78.7) 16,321 (70.5) 9,492 (83) 32,448 (67.6)
Secondary 297 (4.7) 3,034 (12.2) 315 (6.1) 1,969 (8.5) 612 (5.3) 5,003 (10.4)
Post-secondary 552 (8.8) 5,719 (23) 788 (15.2) 4,866 (21.0) 1,340 (11.7) 10,585 (22.0)
Missing 771 1,075 378 957 1,149 2,032
Increased WC 5,444 (77.4) 3,444 (13.3) 2,883 (51.8) 1,221 (5.1) 8,327 (66.1) 4,665 (9.3)
Hypertension 6,439 (91.5) 11,771 (45.4) 5,393 (97) 16,208 (67.2) 11,832 (94.0) 27,979 (55.9)
High triglycerides 6,335 (90.1) 4,189 (16.1) 5,383 (96.9) 9,083 (37.7) 11,718 (93.1) 13,272 (26.5)
Low HDL 5,019 (71.3) 4,040 (15.6) 3,705 (66.7) 1,692(7.0) 8,724 (69.3) 5,732 (11.5)
IGT or diabetes 806 (11.5) 202 (0.8) 713 (12.8) 333 (1.4) 1,519 (12.1) 535 (1.1)
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Metabolic syndrome and THR or TKR: a prospective cohort study
(Table 1). At baseline, women and men had a mean age of 
49.9 years (SD 17.2) and 49.7 years (SD 16.7), respectively. 
Correspondingly, mean age at joint replacement was 69.9 
years (SD 9.3) and 69.0 years (SD 9.2). In total, 1,840 per-
sons received THR (2.9%), and 1,111 persons received TKR 
(1.8%) during a mean follow-up time of 15.4 (SD 4.3) years.
Metabolic syndrome and THR
No association was found between metabolic syndrome or its 
individual components and increased risk of THR (Table 2). 
In the age group <50 years, there was a decreased risk of 
THR in those with the full metabolic syndrome (HR 0.58, 
95% CI 0.40–0.83). There was no substantial difference 
in the analyses in Model 1 and the fully adjusted Model 2. 
However, persons with impaired glucose tolerance or diabe-
tes in the groups 50–69.9 and ≥70 years had a significantly 
decreased risk of THR, with HR 0.65 (95% CI 0.36–0.87) 
and HR 0.30 (95% CI 0.13–0.67). Participants ≥70 years with 
hypertension had a decreased risk of THR (HR 0.63, 95 % 
CI 0.43–0.92). In the youngest age group, <50 years, there 
was also a decreased risk of THR in those with low HDL 
(HR 0.72, 95% CI 0.54–0.94).
Metabolic syndrome and TKR
Metabolic syndrome was not associated with the risk of TKR. 
High waist circumference increased the risk of TKR in the age 
groups <50 years (HR 1.62, 95% CI 1.10–2.39) and 50–69.9 
years (HR 1.43, 95% CI 1.14–1.80), as shown in Table 2. 
Hypertension significantly increased the risk of TKR in 
the age group <50 years (HR 1.38, 95% CI 1.05–1.81). 
Apart from these findings, none of the other components 
of metabolic syndrome were associated with increased risk 
of TKR. However, low HDL was associated with decreased 
risk of TKR in both those <50 years (HR 0.67, 95% CI 
0.49–0.92) and ≥70 years (HR 0.53, 95% CI 0.33–0.86).
Additional analysis
Of the 30,651 persons who participated in both HUNT2 
(1995–1997) and HUNT3 (2006–2008), 31.8% changed the 
exposure group during the follow-up period from normal to 
increased waist circumference and 16.2% changed the expo-
sure group during the follow-up period from no metabolic 
syndrome to metabolic syndrome (Table 3). When analyzing 
only those who had not changed the exposure group in each 
category, there was no longer a decreased risk of THR in 
participants <50 years with metabolic syndrome or low HDL 
(Figure 2). In this analysis, increased waist circumference was 
Table 2 Risk of THR or TKR by metabolic syndrome components and metabolic syndrome
Model 1a Model 2b
<50 years 50–69.9 years ≥70 years <50 years 50–69.9 years ≥70 years
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
THR
Increased waist circumference 1.25 (0.88–1.77) 0.98 (0.83–1.16) 1.19 (0.90–1.57) 1.17 (0.81–1.68) 1.08 (0.89–1.30) 1.22 (0.86–1.73)
Hypertension 1.24 (0.98–1.55) 1.16 (1.00–1.35) 0.63* (0.46–0.87) 1.13 (0.89–1.43) 1.09 (0.93–1.28) 0.63* (0.43–0.92)
High triglycerides 0.92 (0.72–1.17) 0.95 (0.84–1.07) 0.86 (0.70–1.07) 0.86 (0.66–1.11) 0.93 (0.81–1.07) 0.89 (0.69–1.16)
Low HDL 0.71* (0.54–0.93) 0.99 (0.86–1.14) 0.82 (0.64–1.04) 0.72* (0.54–0.94) 0.95 (0.81–1.12) 0.85 (0.62–1.15)
IGT or diabetes 0.73 (0.23–2.29) 0.60* (0.41–0.87) 0.33* (0.18–0.61) 0.78 (0.25–2.44) 0.65* (0.36–0.87) 0.30* (0.13–0.67)
Metabolic syndrome 0.64* (0.46–0.90) 0.94 (0.81–1.09) 0.82 (0.65–1.04) 0.58* (0.40–0.83) 0.93 (0.79–1.10) 0.83 (0.65–1.14)
TKR
Increased waist circumference 1.62* (1.12–2.36) 1.43* (1.16–1.76) 1.45 (0.98–2.15) 1.62* (1.10–2.39) 1.43* (1.14–1.80) 1.55 (0.95–2.53)
Hypertension 1.44* (1.11–1.88) 1.12 (0.91–1.37) 0.76 (0.45–1.30) 1.38* (1.05–1.81) 1.17 (0.93–1.47) 0.68 (0.37–1.25)
High triglycerides 0.97 (0.74–1.27) 1.03 (0.88–1.20) 1.17 (0.86–1.59) 0.97 (0.73–1.28) 1.05 (0.89–1.25) 1.27 (0.87–1.85)
Low HDL 0.62* (0.46–0.84) 0.94 (0.78–1.12) 0.66* (0.46–0.93) 0.67* (0.49–0.92) 1.04 (0.86–1.26) 0.53* (0.33–0.86)
IGT or diabetes 1.01 (0.37–2.73) 0.73 (0.50–1.09) 0.79 (0.45–1.40) 0.85 (0.27–2.66) 0.70 (0.45–1.11) 0.78 (0.38–1.60)
Metabolic syndrome 0.94 (0.68–1.30) 1.07 (0.90–1.28) 1.25 (0.91–1.73) 0.89 (0.63–1.26) 1.16 (0.96–1.41) 1.27 (0.85–1.90)
Notes: *Significant at p<0.05. aModel 1, HR adjusted for gender and BMI. bModel 2, HR adjusted for gender, BMI, smoking, physical activity and education.
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; HR, hazard ratio; IGT, impaired glucose tolerance; THR, total hip replacement; TKR, total knee 
replacement.
Table 3 Number of participants who switched the exposure 
groups during follow-up, including only those who participated in 
both HUNT2 (1995–1997) and HUNT3 (2006–2008) (N=30,651)
From unexposed  
to exposed group, 
n (%)
From exposed to  
unexposed group,  
n (%)
Waist circumference 9735 (31.8) 274 (0.9)
Hypertension 3955 (12.9) 3303 (10.8)
High triglycerides 4767 (15.6) 4296 (14.0)
Low HDL 3175 (10.4) 2331 (7.6)
IGT or diabetes 1115 (3.6) 13 (0.04)
Metabolic syndrome 4971 (16.2) 1428 (4.7)
Abbreviations: HDL, high-density lipoprotein; HUNT2, the Nord-Trøndelag 
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also found to be a risk factor for THR in persons <50 years 
(HR 1.80, 95% CI 1.05–3.10), and there continued to be an 
increased risk of TKR in the age groups <50 years (HR 4.13, 
95% CI 2.15–7.93) and 50–69.9 years (HR 1.43, 95% CI 
1.02–2.01). In contrast to the main analysis, hypertension was 
no longer a protective factor for THR in persons >70 years, 
nor was impaired glucose tolerance or diabetes protective for 
THR in persons between 50 and 69.9 years or >70 years of age.
In a separate sensitivity analysis of the age group <50 
years, participants <30 years at baseline were excluded. 
Hypertension was then only borderline significant (HR 1.29, 
95% CI 0.98–1.70); but apart from this, the results were not 
substantially different from the main analysis (Figure 3).
When stratifying on both gender and age, we found 
increased risk of TKR only in men <50 years with 
 hypertension (HR 1.90, 95% CI 1.16–3.11), as shown in 
Table S2. However, there was still an increased risk of TKR 
in both men and women between 50 and 69.9 years with 
increased waist circumference.
Discussion
In this large prospective study with over 60,000 participants, 
we found no increased risk of THR or TKR in persons 
with metabolic syndrome. There was a reduced risk of 
THR in participants <50 years with metabolic syndrome, 
but this association was no longer significant when exclud-
ing those who changed exposure group during follow-up. We 
found an increased risk of TKR in participants <70 years with 
increased waist circumference and in those <50 years with 
hypertension. Apart from these findings, neither metabolic 
syndrome nor its components increased the risk of THR or 
TKR due to osteoarthritis.
In the main analysis (Table 2), we did not find any 
association between the full metabolic syndrome and 
THR or TKR, except in persons <50 years with metabolic 
syndrome, who were found to have a decreased risk of 
THR (HR 0.58, 95% CI 0.40–0.83). However, our study 
had information on the development of exposure about 10 
years after baseline, and this made it possible to account 
for changes in the exposure status of metabolic syndrome 
during follow-up: 16.2% of those who participated in both 
HUNT2 and HUNT3 went from unexposed to exposed. 
This misclassification of exposure could have affected the 
results. We, therefore, did a sensitivity analysis including 
only those whose exposure status did not change during 
the first 10 years of follow-up and found that metabolic 
syndrome was no longer associated with decreased risk of 
THR in those <50 years. As in the main analysis, in none 
of the other age strata was metabolic syndrome found to 
be a risk factor for THR or TKR. We, therefore, conclude 
that metabolic syndrome is not an important risk factor for 
THR or TKR independent of BMI.
Figure 2 Risk of THR or TKR by metabolic syndrome components and metabolic syndrome including only those patients who did not change exposure groups during 
follow-up. 
Note: HRs adjusted for gender and BMI.
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; HR, hazard ratio; IGT, impaired glucose tolerance; THR, total hip replacement; TKR, total knee 
replacement.
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The high number of participants allowed for stratification 
by age, and thereby the investigation of how some compo-
nents of metabolic syndrome could have different effects 
on risk of total joint replacement in younger and older age 
groups. This could help explain some of the previous con-
flicting results regarding the association between metabolic 
syndrome and total joint replacement; what may be a risk 
factor in those <50 years, such as hypertension or increased 
waist circumference, may not be a risk factor in those ≥70 
years (Table 2). The mechanisms behind this are not clear, but 
it is possible that components of metabolic syndrome could 
be seen as a relative contraindication to joint replacement 
surgery to a higher degree in the old, compared to the young. 
Thus, these components could be protective against surgery, 
but not necessarily osteoarthritis, in the old. Using THR and 
TKR as indicators of osteoarthritis had the advantage of being 
an unambiguous indicator of severe disease burden compared 
to other osteoarthritis definitions, for example, radiographic 
criteria, symptom criteria or osteoarthritis defined by 
 self-reported diagnosis.28 Using total joint replacement as 
an endpoint for osteoarthritis also helps distinguish between 
severe disease and common minor disability.29 However, there 
are several important limitations to this approach. Firstly, per-
sons with moderate osteoarthritis who engage in demanding 
physical activities could be more motivated to have surgery 
than less active persons. Secondly, the metabolic syndrome 
risk factors could influence the orthopedic surgeon’s choice 
regarding treatment, giving a healthy patient selection bias 
with corresponding underestimation of the effect of possible 
risk factors. This effect could have been what we observed 
when we observed that hypertension and increased waist 
circumference were not found to be risk factors in those ≥70 
years. Our findings are also in line with a study by Nielen et 
al which found that risk of severe osteoarthritis necessitating 
THR or TKR decreased with increasing severity of diabetes 
mellitus.30 This could help explain the apparent protective 
effect of impaired glucose tolerance or diabetes in the two 
older age groups.
Figure 3 Risk of THR or TKR by metabolic syndrome components and metabolic syndrome in participants <50 years after excluding participants <30 years at baseline.
Note: HRs adjusted for gender, BMI, smoking, physical activity and education.
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We found an increased risk of TKR in participants <50 
years with hypertension, and this effect was strongest in 
men. Hypertension as a risk factor for TKR is consistent 
with previous findings by Monira Hussain et al.15 In both 
the Chingford study from the UK and the ROAD study 
from Japan, hypertension was found to be associated with 
osteoarthritis of the knee, independent of BMI.17,31 A recent 
study by Niu et al reported that diastolic blood pressure 
was related to incident symptomatic osteoarthritis.18 The 
prevalence of atherosclerotic risk factors, which include 
hypertension, has been reported to be higher in individuals 
with osteoarthritis.32 It has been hypothesized that vascular 
pathology of subchondral small vessels could lead to local 
ischemia and subsequent development of osteoarthritis.33,34 
Le Clanche et al summarized a possible pathologic pathway 
between hypertension and osteoarthritis in a recent review35 
and attributed the connection to a reduced capacity of cells to 
produce nitric oxide, as hypertension causes a narrowing of 
the blood vessels.36 This again leads to reduced blood flow in 
the subchondral bone, and thereby a compromised exchange 
of nutrients and oxygen and degradation of cartilage.34 This 
subchondral ischemia could also induce osteocyte apoptosis 
in the subchondral bone, which again could lead to osteoclast 
recruitment and subchondral bone loss.37
Persons <70 years with increased waist circumference had 
an increased risk of TKR. Our results were concordant with 
several previous studies reporting increased central obesity 
to be a risk factor for osteoarthritis after adjustment for 
BMI.4,15,38 It may be that the increased amount of abdominal 
fat tissue releases inflammatory mediators (adipokines, free 
fatty acids, reactive oxygen species) that, in turn, affect the 
joints and cartilage.13,17,39 Another explanation could be that 
a high BMI may be due to either a large muscle/skeletal 
mass or a large amount of fat tissue. Overweight due to a 
large muscle mass could, therefore, be less harmful for the 
knees than overweight due to a large amount of abdominal 
fat tissue. Waist circumference may, therefore, differentiate 
these two groups.
Strengths and limitations
To the best of our knowledge, this is the largest prospective 
population study addressing the association between meta-
bolic syndrome and total joint replacement due to primary 
osteoarthritis. In most cases, the metabolic syndrome compo-
nents were measured many years prior to joint replacement. 
The ability to adjust for multiple potential confounders was 
a strength in this study. Even though the participation rate 
in HUNT2 was fairly high compared to most other surveys, 
there is always a potential for selection bias.20 In particular, 
men from young age groups had a lower participation rate. 
However, since primary THR and TKR are most common in 
the elderly population, the effect of this selection bias in our 
study population should be minimal.
Information on potential change in exposure group during 
follow-up was also a strength in this study. When excluding 
participants who switched the exposure group during the first 
10 years of follow-up, there was no longer an association 
between hypertension and THR in persons >70 years, nor 
was impaired glucose tolerance or diabetes associated with 
THR in persons between 50 and 69.9 years or >70 years. The 
apparent protective effects of these exposures in the main 
analyses could, therefore, have been due to misclassification 
of exposure.
When analyzing women and men separately, we found 
that increased waist circumference was a risk factor for TKR 
in both genders. However, only men with hypertension had an 
increased risk of TKR. The reason for this difference is not 
clear, as one would expect that an underlying biologic mecha-
nism of subchondral ischemia was the same in both genders. 
Further studies on a possible gender difference in hyperten-
sion and knee osteoarthritis are, therefore, warranted.
THR or TKR is very uncommon in persons <30 years, and 
including this group in the analysis could have distorted the 
results. In a sensitivity analysis excluding those <30 years, 
we found that the risk of TKR in participants with hyper-
tension was weakened (HR 1.29, 95% CI 0.98–1.70). This 
could indicate that including young participants could lead 
to overestimation of the effect of hypertension on TKR, and 
this should be taken into account in further studies.
Participants taking antihypertensive medication and/
or with known diabetes were accounted for in the analysis 
by including them in the hypertensive and impaired glu-
cose tolerance groups, respectively. However, we did not 
have information on cholesterol-lowering medication, and 
this could have resulted in differential misclassification of 
exposure as persons on medication were classified as having 
normal serum levels, thus potentially weakening the associa-
tion between HDL/triglycerides and joint replacement. This 
possible misclassification may explain the reduced risk of 
THR or TKR in persons with low HDL in both the highest 
and lowest age strata (Table 2; Figure 2).
As previously described, a limitation in this study was 
that we only had information on non-fasting serum blood 
glucose. Our cutoff level of serum glucose ≥11.1 mmol/L 
is likely to be a stricter definition of impaired glucose toler-
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any association between impaired glucose tolerance/diabetes 
and joint replacement.
Many participants may have had metabolic syndrome for 
some time before entering the study. This could have led to a 
bias in estimation resulting from studying prevalent exposure 
rather than new exposure.40 We were not able to differentiate 
between new and prevalent cases, and thus, the effect of this 
prevalent cohort bias could have led to an underestimation 
of any association between metabolic syndrome and total 
joint replacement.
Waist circumference and BMI are correlated. Estimating 
the correlation between waist circumference (dichotomous) 
and BMI (continuous) gave an R2 of 0.38 in the age group 
<50 years, 0.43 in the age group 50–69.9 years and 0.42 in 
the age group ≥70 years. This corresponded to a variance 
inflation factor (VIF) of 1.62, 1.75 and 1.72, respectively. 
VIF estimates how much the variance of waist circumference 
is inflated because of dependence on BMI. Thus, a VIF of 
1.62 indicates that the variance of waist circumference is 
62% larger than it would be if it was completely unrelated 
to BMI. There are different opinions on when the correlation 
is high enough to become a problem, but a VIF <4 may be 
acceptable.41 However, it is difficult to exactly estimate the 
effect of increased waist circumference, independent of BMI.
Education is used as an indicator of socioeconomic status, 
and the HRs did not change significantly after adjusting for 
this factor. In addition to this, the hospital care in Norway is 
publicly financed and free of charge for patients. Therefore, 
we do not think that socioeconomic factors represented a 
major confounder in this material.
Previous injuries increase the risk of osteoarthritis, espe-
cially in the knee.42,43 Even though we did not have direct 
information on previous injury, the operating surgeon had to 
report whether the knee joint replacement was due to primary/
idiopathic osteoarthritis or a sequela from fracture, ligament 
injury, meniscal injury, infection, rheumatoid arthritis or 
ankylosing spondylitis. We only included joint replacement 
due to primary/idiopathic osteoarthritis.
Validation of diagnoses from the NAR has only been 
done for young adults <40 years of age undergoing THR 
due to hip dysplasia,44 and is therefore inapplicable to our 
study population. However, numbers from the Danish Hip 
Arthroplasty Registry show a positive predictive value of 
85% regarding the primary hip osteoarthritis diagnosis.45 The 
results from the Danish registry are probably comparable to 
the Norwegian registry.
The main clinical implication of this study was that we 
did not find any increased risk of osteoarthritis in  participants 
with metabolic syndrome. Metabolic syndrome may, there-
fore, not be an effective screening tool for identifying indi-
viduals with increased risk of THR or TKR. It is, however, 
possible to identify two groups that should receive special 
attention in reducing the risk of TKR due to osteoarthritis: 
persons <70 years with increased waist circumference and 
persons <50 years with hypertension. The clinical focus 
should still be mainly on weight reduction, as this is also 
an important first step in the treatment and prevention of 
hypertension.46 However, treatment for the other metabolic 
syndrome components is, of course, still advisable due to 
their association with increased risk of cardiovascular disease.
Conclusion
This study found an increased risk of TKR in men 
<50 years with hypertension and in persons <70 years with 
increased waist circumference. Apart from this, neither 
metabolic syndrome nor its components were associated with 
increased risk of THR or TKR due to primary osteoarthritis.
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Table S1 Graphical evaluation of proportional hazards assumption for Cox regression, using log-minus-log plot for categorical variables 
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Table S2 Risk of THR or TKR by metabolic syndrome components and metabolic syndrome stratified on gender and agea
Women Men
<50 years 50–69.9 years ≥70 years <50 years 50–69.9 years ≥70 years
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
THR
Increased waist circumference 1.35 (0.88–2.08) 1.05 (0.83–1.32) 1.25 (0.81–1.92) 0.78 (0.39–1.58) 1.15 (0.83–1.59) 1.15 (0.63–2.09)
Hypertension 1.25 (0.94–1.66) 1.10 (0.90–1.35) 0.54* (0.33–0.88) 0.92 (0.62–1.38) 1.09 (0.82–1.45) 0.77 (0.42–1.43)
High triglycerides 0.94 (0.68–1.32) 1.00 (0.84–1.19) 1.04 (0.74–1.44) 0.74 (0.50–1.10) 0.82 (0.66–1.01) 0.66 (0.43–1.01)
Low HDL 0.75 (0.54–1.03 0.96 (0.79–1.16 0.91 (0.63–1.31) 0.62 (0.36–1.07) 0.93 (0.70–1.23) 0.71 (0.40–1.25)
IGT or diabetes No exposed cases 0.48* (0.25–0.93) 0.34* (0.12–0.92) 2.31 (0.73–7.32) 0.65 (0.35–1.18) 0.24* (0.06–0.99)
Metabolic syndrome 0.61* (0.39–0.95) 0.96 (0.78–1.18) 0.92 (0.64–1.32) 0.51* (0.27–0.94) 0.86 (0.65–1.14) 0.68 (0.40–1.16)
TKR
Increased waist circumference 1.48 (0.90–2.43) 1.34* (1.01–1.78) 1.59 (0.86–2.94) 1.76 (0.94–3.30) 1.65* (1.12–2.44) 1.51 (0.65–3.50)
Hypertension 1.15 (0.81–1.62) 1.09 (0.83–1.43) 0.62 (0.28–1.37) 1.90* (1.16–3.11) 1.40 (0.92–2.14) 0.80 (0.31–2.08)
High triglycerides 0.77 (0.51–1.16) 1.17 (0.94–1.45) 1.26 (0.78–2.02) 1.19 (0.79–1.80) 0.87 (0.65–1.15) 1.35 (0.71–2.58)
Low HDL 0.69 (0.47–1.02) 1.17 (0.93–1.48) 0.72 (0.43–1.20) 0.62 (0.36–1.06) 0.77 (0.53–1.12) 0.16* (0.04–0.68)
IGT or diabetes 0.94 (0.40–2.18) 0.28* (0.12–0.68) 0.94 (0.40–2.18) 0.67 (0.09–4.84) 1.38 (0.81–2.35) 0.52 (0.13–2.17)
Metabolic syndrome 0.86 (0.54–1.37) 1.28* (1.01–1.63) 1.46 (0.89–2.40) 0.87 (0.51–1.47) 0.95 (0.67–1.34) 1.01 (0.50–2.07)
Notes: *Significant at p<0.05. aHRs adjusted for BMI, smoking, education and physical activity.
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